In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Immunovant Inc (NASDAQ: IMVT) closed at $23.32 in the last session, up 3.23% from day before closing price of $22.59. In other words, the price has increased by $3.23 from its previous closing price. On the day, 1.45 million shares were traded. IMVT stock price reached its highest trading level at $23.45 during the session, while it also had its lowest trading level at $22.43.
Ratios:
We take a closer look at IMVT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.07 and its Current Ratio is at 9.07. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Truist on October 14, 2025, initiated with a Hold rating and assigned the stock a target price of $16.
On March 03, 2025, Jefferies started tracking the stock assigning a Hold rating and target price of $20.Jefferies initiated its Hold rating on March 03, 2025, with a $20 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 20 ’25 when Gloria Melanie sold 12,626 shares for $23.62 per share. The transaction valued at 298,237 led to the insider holds 173,511 shares of the business.
Geffner Michael sold 2,595 shares of IMVT for $49,383 on Oct 22 ’25. The Chief Medical Officer now owns 217,958 shares after completing the transaction at $19.03 per share. On Oct 22 ’25, another insider, Stout Jay S, who serves as the Chief Technology Officer of the company, sold 2,520 shares for $19.03 each. As a result, the insider received 47,956 and left with 200,814 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 4087448576 and an Enterprise Value of 3565578496.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.58, which has changed by -0.16826212 over the last 52 weeks, in comparison to a change of 0.09654534 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $29.49, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is 19.49%, while the 200-Day Moving Average is calculated to be 34.73%.
Shares Statistics:
According to the various share statistics, IMVT traded on average about 1.76M shares per day over the past 3-months and 1391080 shares per day over the past 10 days. A total of 174.53M shares are outstanding, with a floating share count of 73.66M. Insiders hold about 57.98% of the company’s shares, while institutions hold 54.83% stake in the company. Shares short for IMVT as of 1761868800 were 16214977 with a Short Ratio of 9.21, compared to 1759190400 on 16268540. Therefore, it implies a Short% of Shares Outstanding of 16214977 and a Short% of Float of 27.029999999999998.
Earnings Estimates
The firm’s stock currently is rated by 10.0 analysts. The consensus estimate for the next quarter is -$0.7, with high estimates of -$0.57 and low estimates of -$0.79.
Analysts are recommending an EPS of between -$2.54 and -$3.34 for the fiscal current year, implying an average EPS of -$2.97. EPS for the following year is -$3.0, with 11.0 analysts recommending between -$1.96 and -$3.98.
